ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd has been granted a patent by the European Patent Office for its 'A Biofiller for Rubber Reinforcement' technology.
Godavari Biorefineries Limited submitted its 2025-26 Annual Report, prior to the 71st Annual General Meeting scheduled for September 28, 2026.
Godavari Biorefineries Ltd issued the notice for its 71st Annual General Meeting, scheduled for September 28, 2026, via video conferencing.
Godavari Biorefineries Ltd received a show-cause notice from the Karnataka Commercial Tax Department for GST-related short payments totaling approximately ₹18.13 Crore.
Godavari Biorefineries received a GST show-cause notice of ₹17.02 Crore for the period 2021-2024. The company is evaluating the claim and preparing its legal response.
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries received a European patent for an anti-cancer pharmaceutical composition. This grant strengthens the company's oncology-focused intellectual property portfolio and therapeutic potential.
Godavari Biorefineries reported Q1 FY27 total income of ₹559.9 Cr, up 4.9% YoY. Strategy focuses on bio-based chemicals and ethanol capacity expansion.
Godavari Biorefineries released its Q1 FY27 financial results. The company successfully commissioned a new 200 KLPD grain-based distillery in Sameerwadi, enhancing total ethanol capacity.
Godavari Biorefineries Ltd reported revenue from operations of ₹557.9 Cr (+4.6% YoY) and a net loss of ₹19.3 Cr for Q1 FY27.
Godavari Biorefineries Ltd scheduled a board meeting for August 5, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Godavari Biorefineries Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026. This filing discloses the distribution of shareholding among various investor categories.
Godavari Biorefineries re-appointed Nitin Mehta as Independent Director and Sangeeta Srivastava as Whole Time Director. These appointments follow shareholder approval via postal ballot.
Godavari Biorefineries is investing Rs.130 Crore to add 200 KLPD distillery capacity. The expansion provides dual-feedstock capability to meet rising ethanol blending demand.
Godavari Biorefineries Ltd announced the voting results of its postal ballot. Shareholders approved the re-appointment of Mr. Nitin Mehta and Dr. Sangeeta Srivastava.
Godavari Biorefineries commenced operations at its Sameerwadi corn-based distillery. The project involved a ₹130 Crore investment with 200 KLPD capacity.
Godavari Biorefineries Ltd announced that the Japanese Patent Office granted its patent “5‑HYDROXY‑1,4‑NAPHTHALENEDIONE for use in cancer treatment.” The grant enhances the company’s IP portfolio for oncology therapeutics.
Godavari Biorefineries delivered a turnaround in FY26, reporting ₹2,000 cr total income and a positive PAT of ₹3.5 cr, driven by operational efficiencies and debt reduction.
Godavari Biorefineries was granted an Indian patent for a safe, cost-effective branched alcohol production process. This grant strengthens its bio-based chemicals intellectual property portfolio.
Godavari Biorefineries Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The auditor confirmed zero non-compliance issues or penalties for the period.
Godavari Biorefineries reported FY26 total income of ₹2,000.2 Cr, up 6% YoY, with EBITDA margins stabilizing at 7% as the company shifts towards high-margin bio-based specialty chemicals.
Godavari Biorefineries issued a postal ballot notice for re-appointing an Independent Director and an Executive Director. Shareholders can cast votes electronically until June 28, 2026.
Godavari Biorefineries reported Q4 FY26 total income of ₹570.0 Crore. The results show resilient performance despite industry headwinds and elevated feedstock costs affecting profitability.
Godavari Biorefineries Ltd reported revenue from operations of ₹564.1 Cr (-2.7% YoY) and net profit of ₹52.9 Cr (-26.4% YoY) for Q4 FY26.
Godavari Biorefineries reported a total consolidated income of ₹2000.15 Crore for the fiscal year 2026. The board also approved re-appointments of key executive and independent directors.
Godavari Biorefineries scheduled a board meeting for May 22, 2026, to approve yearly audited financial results. Trading window remains closed until May 24, 2026.
Godavari Biorefineries Ltd disclosed its status under the SEBI Large Corporate framework, reporting outstanding borrowings of ₹330.93 Crore as of March 31, 2026. The company carries a CARE BBB+ credit rating.
Godavari Biorefineries Ltd achieved a record crushing of 2.5 million tonnes of sugarcane at its Sameerwadi unit during the 2025-26 session. This represents the highest-ever crushing in the company's history. The current crushing session is scheduled to conclude on April 7, 2026.